DRTS — Alpha Tau Medical Ltd.

Hisse detayı

—
— —
—

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Hand: pan · Wheel: zoom · Right axis drag/wheel: price scale · Bottom axis drag/wheel: date scale · Double-click: auto scale · Esc cancel

Positive Day Ratio (PDR) / Relative Strength (RS)

Financial & Technical Snapshot

Stock / Sector % Change